Financials
Financial year 2025
Revenue
€ 118.4 million
▼ 16% vs 2024
Profit
Healthy€ 3.2 million
▼ 23% vs 2024
Debts
Low€ 33 million
▲ 1% vs 2024
GILEAD SCIENCES BELGIUM from Machelen (Brab.), company number BE0882565584, closed financial year 2025 with a result of € 3.2 million after tax. For that financial year GILEAD SCIENCES BELGIUM recorded revenue of € 118.4 million and equity of € 35.7 million. Compared with financial year 2024, the result moved from € 4.1 million to € 3.2 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.
What happened at GILEAD SCIENCES BELGIUM?
What happened at GILEAD SCIENCES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3.2 million (▼ 23% vs 2024). Source: NBB ↗
- Juan Peche Marin-Lázaro became a director. NBB
- Josephine Yang Comiskey became a director. NBB
- Luis Eduardo Viana De Oliveira Martins became a director. NBB
- Sabine Tews became a director. NBB
- Hans York-Julian Stücker became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 1.8 million profit in 2021 to € 3.2 million profit in 2025.
Paid € 7.2 million in corporate taxes since 2021.
Best year ever: 2023, with € 5.3 million profit.
Pays suppliers within 110 days on average.
A new publication or filing at GILEAD SCIENCES BELGIUM? We notify you, reason included.
Follow GILEAD SCIENCES BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind GILEAD SCIENCES BELGIUM are Hans York-Julian Stücker, Sabine Tews, Juan Peche Marin-Lázaro, Josephine Yang Comiskey and Luis Eduardo Viana De Oliveira Martins. The shares are held by Gilead Sciences Ireland UC (100%).
Directors
According to the 2025 annual accounts
Hans York-Julian Stücker
Director
since 2023
Sabine Tews
Managing director
since 2024
Juan Peche Marin-Lázaro
Director
since 2025
Josephine Yang Comiskey
Director
since 2024
Luis Eduardo Viana De Oliveira Martins
Managing director
since 2024
Shareholders
Gilead Sciences Ireland UC
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Culliganlaan 2D
1831 Machelen (Brab.)
Culliganlaan 2 box D
1831 Machelen (Brab.)
Active since 17 July 2006
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0882.565.584
- VAT number
- BE 0882.565.584
- Registered office
- Culliganlaan 2D, 1831 Machelen (Brab.)
- Names & denominations
- GILEAD SCIENCES BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 July 2006
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen